Atherogenic vascular stiffness and hypertension: Cause or effect?

JAMA

Volumn 308, Issue 9, 2012, Pages 919-920

  Mukherjee, Debabrata ^a  

^a Paul L Foster School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; POLYPILL; SIMVASTATIN; UNCLASSIFIED DRUG;

ARTERIAL STIFFNESS; ATHEROGENESIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DRUG DOSE ESCALATION; DRUG EFFICACY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; EXERCISE; HEMODYNAMICS; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; MICROVASCULARIZATION; MORTALITY; OSCILLOMETRY; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TREATMENT OUTCOME; VASCULARIZATION; VISCOELASTICITY; WEIGHT REDUCTION; FEMALE; MALE; NOTE; PHYSIOLOGY;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; VASCULAR STIFFNESS;

EID: 84865682905     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/2012.jama.10931     Document Type: Editorial

References (18)

1. Leung S, Mukherjee D. Contemporary management of hypertension - how to optimize therapy. Cardiovasc Hematol Disord Drug Targets. 2009;9(3):181-192.
2. National Center for Health Statistics. Health, United States, 2008: with special feature on the health of young adults. http://www.cdc.gov/nchs/data/hus/ hus08.pdf. Accessed August 5, 2012.
3. Lloyd-Jones D, Adams R, Carnethon M, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-e181.
4. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287(8):1003-1010. (Pubitemid 34252058)
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217- 223. (Pubitemid 40138015)
6. Aatola H, Hutri-Kähönen N, Juonala M, et al. Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension. 2010;55(3):806-811.
7. Liao D, Arnett DK, Tyroler HA, et al. Arterial stiffness and the development of hypertension: the ARIC study. Hypertension. 1999;34(2):201-206. (Pubitemid 29409215)
8. Takase H, Dohi Y, Toriyama T, et al. Brachial-ankle pulse wave velocity predicts increase in blood pressure and onset of hypertension. Am J Hypertens. 2011;24(6):667-673.
9. Dernellis J, Panaretou M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension. 2005;45(3):426-431. (Pubitemid 40315813)
10. Najjar SS, Scuteri A, Shetty V, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2008;51(14):1377-1383. (Pubitemid 351443076)
11. Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875-881.
12. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension. Eur Heart J. 2007;28(12):1462-1536. (Pubitemid 47351115)
13. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168-175. (Pubitemid 36231924)
14. Winer N, Weber MA, Sowers JR. The effect of antihypertensive drugs on vascular compliance. Curr Hypertens Rep. 2001;3(4):297-304.
15. Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther. 2003;1(1):65-78.
16. Duprez DA. Is vascular stiffness a target for therapy? Cardiovasc Drugs Ther. 2010;24(4):305-310.
17. Wald DS, Morris JK, Wald NJ. Randomized polypill crossover trial in people aged 50 and over. PLoS One. 2012;7(7):e41297.
18. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109(6):745-749. (Pubitemid 38222894)